Detalles de la búsqueda
1.
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.
Pharmacoepidemiol Drug Saf
; 21 Suppl 2: 37-43, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22552978
2.
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia.
Clin Transl Oncol
; 23(10): 2141-2154, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33948920
3.
Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891.
Leukemia
; 19(12): 2054-62, 2005 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16136168
4.
Postremission therapy for children with acute myeloid leukemia: the children's cancer group experience in the transplant era.
Leukemia
; 19(6): 965-70, 2005 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-15830007
5.
Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia
Clin. transl. oncol. (Print)
; 23(10): 2141-2154, oct. 2021. graf, tab
Artículo
en Inglés
| IBECS (España) | ID: ibc-223385
6.
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.
Oncogene
; 18(35): 4948-57, 1999 Sep 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-10490829
7.
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study.
J Clin Oncol
; 18(24): 4067-76, 2000 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11118468
8.
Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a children's cancer group study.
J Clin Oncol
; 18(1): 18-26, 2000 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-10623689
9.
Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study.
J Clin Oncol
; 18(3): 477-86, 2000 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-10653863
10.
Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study.
J Clin Oncol
; 18(6): 1260-8, 2000 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-10715296
11.
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
J Clin Oncol
; 16(4): 1256-64, 1998 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-9552023
12.
Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Cancer Group study.
J Clin Oncol
; 18(9): 1888-99, 2000 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-10784629
13.
High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.
J Clin Oncol
; 19(11): 2812-20, 2001 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-11387352
14.
PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group.
Leukemia
; 18(11): 1831-4, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15385933
15.
A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group.
Leukemia
; 30(10): 2077-2080, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27133823
16.
Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group.
Leukemia
; 29(12): 2424-6, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26126966
17.
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Leukemia
; 24(5): 909-13, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20376086
18.
DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.
Leukemia
; 22(2): 265-72, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18033323
19.
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
Leukemia
; 25(6): 1039-42, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21358716
20.
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma.
Cancer
; 88(12): 2838-44, 2000 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-10870069